Alumni raised $1.45B in 2022 - Download Free Report Now

Fate Therapeutics, Inc.

Non-epigenetic cell reprogramming technology that enables the generation of patient-identical replacement tissue/organs on an as-needed basis.

Start Trial Get Full Profile

There’s no risk. Start your trial today to see profiles of Fate Therapeutics, Inc. plus 5517 other startups.

Start Free 7 Day Trial Now

Learn More About Fate Therapeutics, Inc.

Technology/product details

Competing Startups


Companies We Work With